CTRI Number |
CTRI/2024/07/069895 [Registered on: 04/07/2024] Trial Registered Prospectively |
Last Modified On: |
03/07/2024 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Other (Specify) [Repetitive Trans Magnetic Stimulation: Neuromodulation] |
Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
Public Title of Study
|
Effectiveness of repetitive trans magnetic stimulation on craving among the tobacco users |
Scientific Title of Study
|
A double-blind, randomised study with repetitive transcranial magnetic stimulation and nicotine replacement therapy versus nicotine replacement therapy alone on cue-induced craving of both smoke and smokeless tobacco users. |
Trial Acronym |
Nil |
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Nukapeyya Santhosmitha |
Designation |
Post graduate |
Affiliation |
ESIC Medical College and Hospital, Sanathnagar, Hyderabad. |
Address |
Room.no-210,Department of Psychiatry, 2nd floor, OPD building, ESIC Medical College and Hospital, Sanathnagar, Hyderabad.
Hyderabad TELANGANA 500038 India |
Phone |
8897848550 |
Fax |
|
Email |
moony0106@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Naveen Kumar Dhagudu |
Designation |
Professor and HOD |
Affiliation |
ESIC Medical College and Hospital, Sanathnagar, Hyderabad. |
Address |
Room.no-210, Department of Psychiatry, 2nd floor, OPD building, ESIC Medical College and Hospital, Sanathnagar, Hyderabad.
Hyderabad TELANGANA 500038 India |
Phone |
8897848550 |
Fax |
|
Email |
naveendhagudu@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Nukapeyya Santhosmitha |
Designation |
Post graduate |
Affiliation |
ESIC Medical College and Hospital, Sanathnagar, Hyderabad. |
Address |
Room.no-210, Department of Psychiatry, 2nd floor, OPD building, ESIC Medical College and Hospital, Sanathnagar, Hyderabad.
Hyderabad TELANGANA 500038 India |
Phone |
8897848550 |
Fax |
|
Email |
moony0106@gmail.com |
|
Source of Monetary or Material Support
|
ESIC Medical College and Hospital, Sanathnagar, Hyderabad, Telangana, India, 500038. |
|
Primary Sponsor
|
Name |
ESIC Medical College and Hospital |
Address |
Sanathnagar, Hyderabad, Telangana, India, 500038. |
Type of Sponsor |
Government medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Naveen Kumar Dhagudu |
ESIC Medical College and Hospital, Sanathnagar, Hyderabad. |
Room.No-210,Department of Psychiatry, 2nd Floor, OPD Building. Hyderabad TELANGANA |
09247266680
naveendhagudu@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethics Committee, ESIC Medical College and Hospital and ESIC Super Speciality Hospital |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: F172||Nicotine dependence, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Repetitive Trans Magnetic Stimulation |
Site of pulses: Left DLPFC
Target method:5 cm anterior and lateral to thumb area
Number of sessions: 10
Frequency:20Hz
Intensity (%RMT): 100%
Total pulses: 1200
|
Comparator Agent |
Sham |
Site of pulses: Left DLPFC Target method:5 cm anterior and lateral to thumb area Number of sessions: 10 Frequency: -
Intensity (%RMT): - Total pulses: -
Sham method: sham coil |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
60.00 Year(s) |
Gender |
Both |
Details |
1)Patients who have Nicotine dependence as per ICD-10.
2) Subjects who are cooperative and willing to give written informed consent for participation in the study.
3) Subjects who answer satisfactorily on a safety screening questionnaire for rTMS.
4) patients who started NRT for their tobacco dependence.
5) Mandatory 2 hours of abstinence from tobacco before the rTMS procedure.
6) Right-handedness individuals.
7) Patients with 5 or more failed other interventional methods. |
|
ExclusionCriteria |
Details |
1) Patients with other active psychiatry disorder diagnosed according to DSM-5.
2) Use of any psychotropic medications on a regular basis.
3) Any other substance use disorder during last 12 months.
4) History of epilepsy or increased risk of seizures for any reason.
5) Any significant neurological disorder or insult.
6) Patients with acute physical illness.
7) Known or suspected pregnancy or lactation.
8) Patients with intra-cranial implants, pacemakers, cochlear implants, implantation of medication pumps.
9)Patients who underwent DBS. |
|
Method of Generating Random Sequence
|
Coin toss, Lottery, toss of dice, shuffling cards etc |
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
Blinding/Masking
|
Participant and Investigator Blinded |
Primary Outcome
|
Outcome |
TimePoints |
Craving reduction(cue induced) |
Baseline, after 5th session, after 10th session, 1 week follow up and 1 month follow up. |
|
Secondary Outcome
|
Outcome |
TimePoints |
To study the quantity( number of chews or number of cigarettes) of consumption of tobacco use since last 1 week. ( self report) |
Baseline, after 5th session, after 10th session, 1 week follow up and 1 month follow up. |
To assess the change of severity of tobacco dependence. |
Baseline, after 5th session, after 10th session, 1 week follow up and 1 month follow up. |
To assess the point prevalence of abstinence of tobacco use since last 7 days ( self report). |
Baseline, after 5th session, after 10th session, 1 week follow up and 1 month follow up. |
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 3 |
Date of First Enrollment (India)
|
15/07/2024 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
Not Applicable yet |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identification.
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form
- Who will be able to view these files?
Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
- For what types of analyses will this data be available?
Response - To achieve aims in the approved proposal.
- By what mechanism will data be made available?
Response - Proposals should be directed to [moony0106@gmail.com].
- For how long will this data be available start date provided 01-01-2024 and end date provided 01-10-2022?
Response - Beginning 9 months and ending 36 months following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
Brief Summary
|
This is a post-graduate thesis project started with the intent to evaluate the effect of repetitive Transcranial Magnetic Stimulation on the cue-induced craving of tobacco dependence, who are on Nicotine Replacement therapy. To study this aim we planned the objectives followed: Primary objective: To study the effectiveness of craving reduction in tobacco users by the rTMS intervention compared to sham-controlled. Secondary objectives: To study the quantity( number of chews or number of cigarettes) of consumption of tobacco use over the last 1 week. (self-report); To assess the change of severity of tobacco dependence; To assess the point prevalence of abstinence of tobacco use over the last 7 days (self-report). The design of this study is an experimental, double-blind, randomized controlled design. Study intervention is 20 Hz, 1200 pulses high frequency of rTMS on left DLPFC site with sham control. Study subjects will be recruited as a purposive sampling method at ESIC MCH, Hyderabad. The target sample size will be 30. study duration planned to conduct in 18 months duration from November 1st 2022 onwards.. potential study subjects will be selected with, Inclusion Criteria: 1) Age: 18-60 years 2) Patients who have Nicotine dependence as per ICD-10. 3) Subjects who are cooperative and willing to give written informed consent for participation in the study. 4) Subjects who answer satisfactorily on a safety screening questionnaire for rTMS. 5) patients who started NRT for their tobacco dependence. 6) Mandatory 2 hours of abstinence from tobacco before the rTMS procedure. 7) Right-handedness individuals. 8) Patients with 5 or more failed other interventional methods. G.Exclusion Criteria: 1) Patients with other active psychiatry disorders diagnosed according to DSM-5. 2) Use of any psychotropic medications on a regular basis. 3) Any other substance use disorder during the last 12 months. 4) History of epilepsy or increased risk of seizures for any reason. 5) Any significant neurological disorder or insult. 6) Patients with acute physical illness. 7) Known or suspected pregnancy or lactation. 8) Patients with intra-cranial implants, pacemakers, cochlear implants, implantation of medication pumps. 9)Patients who underwent DBS. Study instruments that will be used to assess the dependence and cue-induced craving are Fagerstrom Test for Nicotine Dependence (FTND), Minnesota Nicotine Withdrawal Scale(MNWS) and Tobacco Cue Questionnaire (TCQ). These are used to assess the study objectives at baseline, after the 5th session, after the 10th session, 1 week and 1 month after the intervention. Will take all ethical precautions and submit them to the institutional ethics committee and wait for approval. Statistical analysis will be planned for parametric variables with paired t-test or chi-square test and ANOVA (smoker, smokeless tobacco users and dual users) are used and for the non-parametric variables, Wilcoxon rank-sum test or Fisher’s exact test and Kushal Wallis H test (smoker, smokeless tobacco users and dual users) are used. Data analysis is done by using IBM SPSS Statistics software and the information is maintained confidential. |